Biochemical activities of Curcuminoid analogues with Methyl substituted phenyl ring and their Transition metal chelates

  • Seena Thomachan
  • S. Sindhu
  • John V D
Keywords: 1,7–diarylheptanoids, IR, NMR, mass spectra, antitumour, cytotoxicity, antibacterial

Abstract

In recent years there has been an increased enthusiasm in treating the diseases by natural
products.Curcumin has found a wide application in this context.Curcumin and its analogues have been
extensively studied for their biological activities including antimicrobial,antiinflammatory,antioxidant,anticarcinogenic etc. Recently a number of compounds structurally related to
curcuminoids were synthesized and their chemotherapeutic potential has been revealed. In the present study, the
synthesis and characterization of two curcuminoid analogues with methyl substituted phenyl ring and their
metal chelates Cu(II),Zn(II),Oxovanadium(IV)&Ni(II) are discussed here. The curcuminoid analogues
namely 1,7-bis(2-methyl phenyl)hepta-1,6-diene-3,5-dione(L1) and 1,7-bis(2,5-dimethyl phenyl)hepta-1,6-
diene-3,5-dione(L2) and their metal chelates were synthesized and were characterized using UV, IR, 1H NMR
and mass spectral data. In vitro cytotoxic studies were done with ligands and metal complexes against EAC
cells(Ehrilch Ascites Carcinoma) using Trypan blue exclusion method and antibacterial study of the compounds
were done using agar well diffusion method. The in vivo antitumour activity of the ligand and complexes were
determined by using DLA cells(Daltons Lymphoma Ascites) in mice and compared with standard anticancer
drug cyclophosphamide. The life spans of the treated animals were increased. The present investigation reveals
that the Cu(II) complexes show enhanced cytotoxic activity and antibacterial activity than the curcuminoid
analogues ,Zn(II),Ni(II) and Oxovanadium(IV) complex.

Downloads

Download data is not yet available.

References

[1] Al-Hujaily,E.M., Mohamed,A.G., Al-Sharif, I.(2011)PAC- a novel curcumin analogue, has anti-breast cancer properties with higher
efficiency on ER-negative cells. Breast Cancer Res Treat. 128,97–107
[2]Azuine, M.A, Bhide, V.(1992) Chemo preventive effect of turmeric against stomach and skin tumours induced by chemical carcinogens
in Swiss mice. Nutrition Cancer. 17(1), 77-83.
[3]Chainani-Wu, N(2003). Safety and Anti-Inflammatory Activity of Curcumin. J. Altern. Complement. Med. 9,161-8
[4]Chandra, D., Gupta, S.S.(1972) Anti inflammatory and anti arthritic activity of volatile oil. Indian Journal of Medical
Research. ,60, 138-140.
[5]Clare, M.J., Hydes, D.C. In: Sigel H (Ed.)(1979). Metal ions in biological systems, metal complexes as anticancer drugs. Marcel Decker,
New York: p. 1-62.
[6] Fadda,A., Badria ,F., El-Attar,K.(2010) Synthesis and evaluation of curcumin analogues as cytotoxic agents.Medicinal Chemistry
Research. 19,413–30.
[7]Holt, P.R., Katz, S., Kirshoff, R.(2005) Curcumin therapy in inflammatory bowel disease: a pilot study. Dig. Dis. Sci., 50.
[8]Iqbal, M., Sharma, S.D., Okazaki, Y., Fujisawa, M., Okada, S.(2003) Dietary supplementation of curcumin enhances antioxidant and
Phase II metabolizing enzymes in ddy male mice: possible role in protection against chemical carcinogenesis and
toxicity. Pharmacol.Toxicol, 1, 92.
[9]Kostova, D., Albena ,T., Paul, T.(1999) Relation of structure of curcumin analogues to their potencies as inducers ofphase-2 detoxifica
tion enzymes. Carcinogenesis. 20, 911-919.
[ 10]Krishnankutty, K., John, V.D.(2003) Synthesis, characterization and antitumour studies of metal chelates of some synthetic
curcuminoids. Synhesis and Reactivity in Inorganic Metal-Organic Chemistry. 33, 343-358
[11]Krishnankutty, K., John ,V.D., Kuttan, G.(2002) Antitumour studies of metal chelates of synthetic curcuminoids. Journal of Experimental and Clinical Cancer Research. 21, 219-224
[12]Krishnankutty, K., Venugopalan, P.(1998) Metal chelates of curcuminoids. Synthesis and Reactivity in Inorganic MetalOrganic Chemistry. 28,1313-1325.
[13]Kuo, M.L., Huang, T.S., Lin, J.K.(1996)Curcumin, an antioxidant and anti-tumour promoter. Biochim.Biophys.Acta. 2, 1317.
[14]Kuttan, G., Vasudevan, D.M., Kuttan, R(1988). Isolation and identification of a tumour reducing component from mistletoe extract.
Cancer Letters. 41, 307-315
[15]Leu, T.H., Maa, M.C.(2000) The Molecular mechanism for the Antitumorigenic effect of curcumin Curr. Med. Chem. Anticanc Agents, 2
[16]Othman, A., Hamed,Noha Mehdawi,Adhan Abu Taha.(2013)Synthesis and Antibacterial activity of Novel curcumin derivatives
containing Hetero cyclic Moiety.Iran J Pharm Res Winter
[17]Pabon, H.J.J.(1964) A synthesis of curcumin and related compounds. Recueil des TravauxChimiques des Pays-Bas. 83, 237-240.
[18]Raman,N,.Muthuraj,V,.Ravichandran,S.,Kulandaisamy,A.(2003)Synthesis,Characterisation & electrochemical behavior of Cu(II),
Co(II),Ni(II) and Zn(II) complexes derived from acetyl acetone and their antimicrobial activity.Proc.Indian Acad
Sci(Chem.Sci),115(3),161-167
[19]Sharma, R.A., Gescher, A.J., Steward, W.P.(2005) Curcumin: The story so far. Eur. J. Cancer, 41.
[20]Shishodia, S., Sethi, G., Aggarwal, B.B.(2005) Curcumin: getting back to the roots. Ann N Y Acad. Sci , 1056.
[21]Sreejayan, N., Rao, M.N.A.(1994) Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. , 46.
[22]Subramanian, M., Sreejayan, N., Rao, M.N.A, Devasagayam,T.D.A,Singh, B.B(1994). Diminution of singlet oxygen-inducedDNADamage by curcumin and related antioxidants. Mutat Res, 311.
[23] Wilken,R., Veena,M.S., Wang,M.B., Srivatsan,E.S.(2011) Curcumin: A review of anti-cancer properties and therapeutic activity in
head and neck squamous cell carcinoma, Mole. Can. 10, 1-19.
Published
2018-09-12
How to Cite
Thomachan, S., Sindhu, S., & V D, J. (2018). Biochemical activities of Curcuminoid analogues with Methyl substituted phenyl ring and their Transition metal chelates. IJRDO-Journal of Applied Science, 1(4), 33-47. https://doi.org/10.53555/as.v1i4.2316